Insider Shareholders with Direct Ownership of Arcus Biosciences, Inc. (RCUS)
This section provides a comprehensive overview of the insiders with direct ownership of Arcus Biosciences, Inc. (RCUS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Arcus Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction | 
|---|---|---|---|---|---|
| 
                  
                    Gilead Sciences Inc
                  
                   > 10% Shareholder | 23,261,731 | 0 | 31,424,760 $634 Million | 4 |                   
            Feb 18, 2025
              Added 4.16%
           | 
| 
                  
                    Terry J Rosen
                  
                   Chief Executive Officer | 500,948 | 122,989 | 2,554,160 $51.6 Million | 19 |                   
            Feb 27, 2025
              Added 0.77%
           | 
| 
                  
                    Column Group Ii, Lp
                  
                   > 10% Shareholder | 3,540,850 | 0 | 470,427 $9.5 Million | 1 |                   
            Mar 19, 2018
              Added 50.0%
           | 
| 
                  
                    Juan C. Jaen
                  
                   President | 186,425 | 63,598 | 367,220 $7.41 Million | 18 |                   
            Jan 23, 2025
              Added 11.98%
           | 
| 
                  
                    Jennifer Jarrett
                  
                   Chief Operating Officer | 617,342 | 510,532 | 214,232 $4.33 Million | 41 |                   
            Oct 08, 2025
              Reduced 15.0%
           | 
| 
                  
                    Carolyn C. Tang
                  
                   General Counsel | 126,488 | 35,949 | 137,623 $2.78 Million | 17 |                   
            Jan 23, 2025
              Added 21.19%
           | 
| 
                  
                    Ii Robert C. Goeltz
                  
                   Chief Financial Officer | 120,300 | 33,862 | 92,138 $1.86 Million | 15 |                   
            Oct 28, 2025
              Reduced 5.15%
           | 
| 
                  
                    Dimitry Sa Nuyten
                  
                   Chief Medical Officer | 104,500 | 19,996 | 87,518 $1.77 Million | 8 |                   
            Dec 15, 2024
              Reduced 8.24%
           | 
| 
                  
                    Richard Markus
                  
                   Chief Medical Officer | 75,193 | 0 | 75,193 $1.52 Million | 1 |                   
            Feb 10, 2025
              Added 50.0%
           | 
| 
                  
                    David L. Lacey
                  
                   Director | 35,600 | 0 | 70,952 $1.43 Million | 5 |                   
            Jun 10, 2025
              Added 15.79%
           | 
| 
                  
                    Kathryn E Falberg
                  
                   Director | 35,600 | 50,504 | 68,600 $1.39 Million | 6 |                   
            Jun 10, 2025
              Added 16.24%
           | 
| 
                  
                    Antoni Ribas
                  
                   Director | 35,600 | 0 | 43,650 $881,293 | 5 |                   
            Jun 10, 2025
              Added 23.35%
           | 
| 
                  
                    Andrew J Perlman
                  
                   Director | 40,100 | 0 | 42,625 $860,598 | 6 |                   
            Jun 10, 2025
              Added 23.78%
           | 
| 
                  
                    Patrick Machado
                  
                   Director | 35,600 | 0 | 38,600 $779,334 | 5 |                   
            Jun 10, 2025
              Added 25.63%
           | 
| 
                  
                    Nicole Lambert
                  
                   Director | 37,300 | 0 | 37,300 $753,087 | 5 |                   
            Jun 10, 2025
              Added 26.28%
           | 
| 
                  
                    Yasunori Kaneko
                  
                   Director | 59,733 | 0 | 33,300 $672,327 | 7 |                   
            Jun 10, 2025
              Added 28.54%
           | 
| 
                  
                    Alexander Azoy
                  
                   Chief Accounting Officer | 25,950 | 14,620 | 27,363 $552,458 | 13 |                   
            Sep 29, 2025
              Reduced 9.38%
           | 
| 
                  
                    William Grossman
                  
                   Chief Medical Officer | 118,750 | 15,442 | 20,723 $418,397 | 7 |                   
            Jun 17, 2021
              Reduced 15.81%
           |